MedPath

Safety and efficacy assessment of injectable gel with Perleux® brand, in order to rejuvenate facial ski

Phase 2
Recruiting
Conditions
Skin Hydration.
Registration Number
IRCT20150101020514N17
Lead Sponsor
Zist orchid pharmed Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

35 -60 years old men and women
The presence of visible signs of skin aging mainly dry skin, skin roughness, loss of elasticity and clear lines and wrinkles.
Have signed the informed consent form and agree to a 6-month follow-up

Exclusion Criteria

Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment
History of radiofrequency (R-F), rejuvenation lasers or intense pulsed light in the past 6 months
Pregnancy or lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Skin elasticity (R0, R2, R5) measured in right cheek. Timepoint: Before intervention, 8 and 16 weeks later. Method of measurement: By cutometer probe of MPA 580(Multi Probe Adaptor) device.
Secondary Outcome Measures
NameTimeMethod
Thickness and density of dermis. Timepoint: Before intervention, 8 and 16 weeks later. Method of measurement: Skin ultrasound.;Trans Epidermal Water Lost (TEWL) measured in right cheek. Timepoint: Before intervention, 8 and 16 weeks later. Method of measurement: By TEWA probe of MPA 580(Multi Probe Adaptor) device.
© Copyright 2025. All Rights Reserved by MedPath